The advent of next-generation sequencing technologies has greatly promoted advances in the study of human diseases at the genomic, transcriptomic, and epigenetic levels. Exome …
Intratumor heterogeneity (ITH) drives neoplastic progression and therapeutic resistance. We used the bioinformatics tools' expanding ploidy and allele frequency on nested …
Abstract The Cancer Genome Atlas (TCGA) has used the latest sequencing and analysis methods to identify somatic variants across thousands of tumours. Here we present data and …
Detection of somatic point substitutions is a key step in characterizing the cancer genome. However, existing methods typically miss low-allelic-fraction mutations that occur in only a …
SP Shah, A Roth, R Goya, A Oloumi, G Ha, Y Zhao… - Nature, 2012 - nature.com
Primary triple-negative breast cancers (TNBCs), a tumour type defined by lack of oestrogen receptor, progesterone receptor and ERBB2 gene amplification, represent approximately …
S Ling, Z Hu, Z Yang, F Yang, Y Li… - Proceedings of the …, 2015 - National Acad Sciences
The prevailing view that the evolution of cells in a tumor is driven by Darwinian selection has never been rigorously tested. Because selection greatly affects the level of intratumor …
JX Sun, Y He, E Sanford, M Montesion… - PLoS computational …, 2018 - journals.plos.org
A key constraint in genomic testing in oncology is that matched normal specimens are not commonly obtained in clinical practice. Thus, while well-characterized genomic alterations …
JH Lee, M Huynh, JL Silhavy, S Kim, T Dixon-Salazar… - Nature …, 2012 - nature.com
De novo somatic mutations in focal areas are well documented in diseases such as neoplasia but are rarely reported in malformation of the developing brain …
Y Fan, L Xi, DST Hughes, J Zhang, J Zhang, PA Futreal… - Genome biology, 2016 - Springer
Subclonal mutations reveal important features of the genetic architecture of tumors. However, accurate detection of mutations in genetically heterogeneous tumor cell …